Author

Markus W. Löffler

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 2 Research Focus:cell-cell communication· 2 Approach:experimental assay· 2 Organism:human· 2 Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:differential expression· 1 Research Focus:gene regulatory network inference· 1

Frequent Co-Authors

Andreas Schlosser· 2 shared Ana Marcu· 1 shared András Szolek· 1 shared Daniel Johannes Kowalewski· 1 shared Florian Erhard· 1 shared Hans-Georg Rammensee· 1 shared Holger Moch· 1 shared Jian Wang· 1 shared

Activity by Year

2020-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

Andreas Schlosser

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cancer BiologybioRxivPreprintFeb 6, 2024

Peptide-stimulation of autologous T cells reverts immune checkpoint inhibitor resistance of hypermutated colorectal cancer cells

Sandra Schwarz, Su Zhaoran, Mathias Krohn…·Michael Linnebacher

The paper shows that pre-stimulating T cells with tumor-specific peptides can overcome immune checkpoint inhibitor resistance in hypermutated colorectal cancer cells.

DOI 10.1101/2024.02.06.579061

humanbulk RNA-seq

𝕏 PostBluesky

ImmunologybioRxivPreprintJul 9, 2020

The HLA Ligand Atlas - A resource of natural HLA ligands presented on benign tissues

Ana Marcu, Leon Bichmann, Leon Kuchenbecker…·Marian Christoph Neidert

The paper presents the HLA Ligand Atlas, a resource of HLA-I and -II ligands from benign tissues, showing tissue and individual differences and non-canonical ligand origins.

DOI 10.1101/778944

humanproteomics

𝕏 PostBluesky